Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

56.14
-0.1200-0.21%
Volume:1.51M
Turnover:83.65M
Market Cap:4.85B
PE:-12.43
High:56.35
Open:54.05
Low:53.70
Close:56.26
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Hershey, Wingstop

Reuters
·
30 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Visa, Kraft Heinz, Humana

Reuters
·
30 Jul

The 3 Things That Matter for CRISPR Therapeutics Now

Motley Fool
·
29 Jul

CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium

TIPRANKS
·
28 Jul

CRISPR Therapeutics (CRSP) Surges 71% Last Quarter With Inclusion In Russell Indices

Simply Wall St.
·
24 Jul

Crispr Therapeutics Is Maintained at Buy by B of A Securities

Dow Jones
·
23 Jul

CRISPR Therapeutics Pick of the Week at Smart Insider Following Simeon George's Stock Purchase

MT Newswires Live
·
22 Jul

Crispr Therapeutics price target lowered to $78 from $79 at BofA

TIPRANKS
·
22 Jul

AI Biotech Stocks Shined. Recursion Soared 10%; Absci Up 7%; Crispr Up 6%; Beam And Ginkgo Up 3%

Tiger Newspress
·
21 Jul

3 Monster Stocks in the Making to Buy Right Now

Motley Fool
·
21 Jul

Crispr Therapeutics AG Stock Soars Amid Insider Confidence

TIPRANKS
·
19 Jul

CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares

TIPRANKS
·
19 Jul

Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG!

TIPRANKS
·
18 Jul

CRISPR Therapeutics AG Director George Simeon Reports Acquisition of Common Shares

Reuters
·
18 Jul

Crispr Therapeutics AG Stock Soars Amid Strategic Moves

TIPRANKS
·
12 Jul

CRISPR Therapeutics (NasdaqGM:CRSP) Advances Cardiovascular Programs With Promising Trial Results

Simply Wall St.
·
10 Jul

Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics today

TIPRANKS
·
09 Jul

Crispr Therapeutics Price Target Maintained With a $81.00/Share by Needham

Dow Jones
·
08 Jul

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
08 Jul

Crispr Therapeutics AG Stock Soars Amid Clinical Advances

TIPRANKS
·
05 Jul